Davis professor loses breast cancer battle months after community rallied to help find innovative therapies
Danielle Heard Mollel first shared her journey with stage 4 breast cancer with CBS13 in April. The Davis professor and mother ...
NBC New York11h
Black women are more likely than white women to die of all types of breast cancer
Black women are more likely than white women to die from even the most treatable types of breast cancer, a study published ...
Breast cancer at 38 left 1 woman weak and vulnerable. How strength training got her in the best shape of her life
Once Cait Lowry finished breast cancer treatment, weight lifting helped her rebuild muscle, boost her energy and fight brain ...
FDA expands approval of breast cancer drug Kisqali to earlier-stage patients
The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat ...
Breast cancer survivors on LI have one less worry now: Paying for nipple tattoos
"This way you don't have medical patients paying out of pocket for medical care," said Assemb. Amy Paulin, who sponsored the ...
Health Rounds: Breastfeeding is safe for breast cancer survivors
Hello Health Rounds Readers! Today we highlight research findings reported at ESMO 2024, the annual meeting of the European ...
Twin Cities Business1h
Melodi Health Raises $10.75M for Breast Cancer Recovery Device
Worrell said the treatment process for breast cancer takes anywhere from three to six months. It took her friend years to ...
Black Women Face Higher Death Risk From All Types of Breast Cancer
WEDNESDAY, Sept. 18, 2024 (HealthDay News) -- Black women have a higher risk of dying from any type of breast cancer than ...
FDA Expands Use of Breast Cancer Drug Kisqali
While Verzenio, a drug in the same class, has been approved to lower the risk of early breast cancer returning, it's only for ...
Business Insider4h
ECHO Powers On the Fight Against Breast Cancer with Susan G. Komen®
Komen ®, one of the world’s leading breast cancer organizations. The organizations will join forces for the “Power On. For A Cure.” campaign, a powerful initiative aimed at supporting Komen’s mission, ...
Medscape18h
FDA OKs Adjuvant Ribociclib in Earlier Stage Breast Cancer
The US Food and Drug Administration (FDA) approved ribociclib (Kisqali, Novartis) in combination with an aromatase inhibitor ...
Medscape4h
Evolving Conversations in HER2+ Oligometastatic Breast Cancer Management
Drs Kathy D. Miller and Heather A. Parsons explore the complexities and evolving strategies in managing HER2+ oligometastatic ...